The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Genetically Modified Organisms & Synthetic Biology

Engineered probiotic developed to treat multiple sclerosis
Basic & Discovery Research

Engineered probiotic developed to treat multiple sclerosis

AUG 14, 2023
Ilya Pharma’s genetically modified lactic acid bacteria drug candidate effectively accelerates wound healing in clinical study
Basic & Discovery Research

Ilya Pharma’s genetically modified lactic acid bacteria drug candidate effectively accelerates wound healing in clinical study

JUN 1, 2023
SNIPR Biome’s data on drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology
Basic & Discovery Research

SNIPR Biome’s data on drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology

MAY 8, 2023
Researchers create virus-resistant, safely restrained E. coli
Basic & Discovery Research

Researchers create virus-resistant, safely restrained E. coli

APR 10, 2023
Aurealis therapeutics raises $10 million in an oversubscribed series A financing
Finance

Aurealis therapeutics raises $10 million in an oversubscribed series A financing

APR 3, 2023
Engineered bacteria find tumors, then alert the authorities
Basic & Discovery Research

Engineered bacteria find tumors, then alert the authorities

MAR 13, 2023
Key patent issued on Eligo’s gene editing breakthroughs applied to skin disorders
Finance

Key patent issued on Eligo’s gene editing breakthroughs applied to skin disorders

NOV 16, 2022
Protecting the human intestinal microbiome with synthetic biology
Genetically Modified Organisms & Synthetic Biology

Protecting the human intestinal microbiome with synthetic biology

APR 18, 2022
A new photoactive viral vector for anti-cancer therapy has been developed
Genetically Modified Organisms & Synthetic Biology

A new photoactive viral vector for anti-cancer therapy has been developed

MAR 15, 2022
SNIPR BIOME announces opening of new BSL2/GMO2-classified laboratory in Copenhagen, Denmark
Finance

SNIPR BIOME announces opening of new BSL2/GMO2-classified laboratory in Copenhagen, Denmark

MAR 9, 2022
A new strategy for editing DNA within microbial communities using CRISPR-Cas9 technology
Editor's Choice

A new strategy for editing DNA within microbial communities using CRISPR-Cas9 technology

FEB 18, 2022